|
| 38055247 | Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification. | JAMA Cardiol | 2024 |
| 36322056 | Use of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagonlike Peptide-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Disease in Community Practice. | JAMA Cardiol | 2023 |
| 37863760 | Accuracy of incidental visual coronary artery calcium assessment compared with dedicated coronary artery calcium scoring. | J Cardiovasc Comput Tomogr | 2023 |
| 37529931 | Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322â¿¿153 Patients. | Circ Cardiovasc Qual Outcomes | 2023 |
| 37910086 | Prevalence, Awareness, and Treatment of Elevated LDL Cholesterol in US Adults, 1999-2020. | JAMA Cardiol | 2023 |
| 37480922 | 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. | J Am Coll Cardiol | 2023 |
| 37952254 | Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial. | JAMA | 2023 |
| 37610733 | Health Claims and Doses of Fish Oil Supplements in the US. | JAMA Cardiol | 2023 |
| 37647054 | Adverse Childhood Experiences as Social Determinants of Cardiovascular Health. | JAMA Cardiol | 2023 |
| 37929707 | Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. | J Am Heart Assoc | 2023 |
| 37771735 | Is there an association between peri-diagnostic vaccination and clinical outcomes in COVID-19 patients? | Antimicrob Steward Healthc Epidemiol | 2023 |
| 37599197 | Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013-2020. | J Clin Lipidol | 2023 |
| 36947031 | Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020. | JAMA Cardiol | 2023 |
| 37398246 | Associations of Cumulative Perceived Stress with Cardiovascular Risk Factors and Outcomes: Findings from The Dallas Heart Study. | medRxiv | 2023 |
| 37471501 | 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. | Circulation | 2023 |
| 37196972 | Generalizability of an EHR-network dataset to the United States for cardiovascular disease conditions: Comparison of Cerner real world data with the national inpatient sample. | Am Heart J | 2023 |
| 37029056 | Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice. | J Clin Lipidol | 2023 |
| 36478024 | Equity in Clinical Trial Participation Requires Equity in Identification and Treatment of Valvular Heart Disease. | JAMA Cardiol | 2023 |
| 36854117 | Vaccine Decision-making in a Time of Conflicting Recommendations: A Call to Go Beyond Politics. | Pediatr Infect Dis J | 2023 |
| 36848409 | When Opportunity Knocks: Capitalizing on Incidental Coronary Arterial Calcification. | Circulation | 2023 |
| 36598445 | Primary prevention statin therapy in older adults. | Curr Opin Cardiol | 2023 |
| 36383369 | Equitable and Informed Consent in Genetic Studies. | JAMA Cardiol | 2023 |
| 34773457 | Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk: The Debate Is Over. | JAMA Cardiol | 2022 |
| 35773565 | COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next Wave. | Curr Atheroscler Rep | 2022 |
| 35442392 | Communicating the Benefits of Vaccination in Light of Potential Risks. | JAMA Cardiol | 2022 |
| 35441656 | The effect of CETP inhibitors on new-onset diabetes: a systematic review and meta-analysis. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 35506143 | Limitations of Observational Studies for Aspirin in Primary Prevention and the Need for Randomized Trials. | Radiol Cardiothorac Imaging | 2022 |
| 35793094 | Machine Learning-Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure. | JAMA Cardiol | 2022 |
| 35793080 | Time to Revisit Using 10-Year Risk to Guide Statin Therapy. | JAMA Cardiol | 2022 |
| 35681104 | A life-course approach to cardiovascular disease prevention. | Nat Med | 2022 |
| 36439649 | Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop. | Am J Prev Cardiol | 2022 |
| 35997751 | Statin Recommendations for Primary Prevention: More of the Same or Time for a Change? | JAMA | 2022 |
| 35988510 | Using EHR data to identify coronavirus infections in hospitalized patients: Impact of case definitions on disease surveillance. | Int J Med Inform | 2022 |
| 36346063 | Trends in Oral Anticoagulant Use Among 436â¿¿864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020. | J Am Heart Assoc | 2022 |
| 34977918 | Underdiagnosis of familial hypercholesterolaemia: innovation is overdue. | Eur Heart J | 2022 |
| 35210038 | Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2022 |
| 35114251 | Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: A systematic review and meta-analysis of randomized controlled trials. | Prog Cardiovasc Dis | 2022 |
| 34902314 | Trends of blood pressure control in the U.S. during the COVID-19 pandemic. | Am Heart J | 2022 |
| 34894377 | Use of negative control outcomes to assess the comparability of patients initiating lipid-lowering therapies. | Pharmacoepidemiol Drug Saf | 2022 |
| 34705021 | The Potential and Pitfalls of Coronary Artery Calcium Scoring. | JAMA Cardiol | 2022 |
| 32902560 | Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database. | JAMA Cardiol | 2021 |
| 33719496 | Effects of Influenza Vaccine on Mortality and Cardiovascular Outcomes in Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. | J Am Heart Assoc | 2021 |
| 33766264 | New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4. | J Am Coll Cardiol | 2021 |
| 33904340 | Adoption of PCSK9 Inhibitors Among Patients With Atherosclerotic Disease. | J Am Heart Assoc | 2021 |
| 33821686 | Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans. | J Am Heart Assoc | 2021 |
| 33615285 | U.S. population at increased risk of severe illness from COVID-19. | Am J Prev Cardiol | 2021 |
| 33582446 | The incremental value of angiographic features for predicting recurrent cardiovascular events: Insights from the Duke Databank for Cardiovascular Disease. | Atherosclerosis | 2021 |
| 33688913 | Incremental Benefits of Machine Learning-When Do We Need a Better Mousetrap? | JAMA Cardiol | 2021 |
| 34916542 | Author Correction: Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk. | Sci Rep | 2021 |
| 35024056 | Asian Pacific Society of Cardiology Consensus Recommendations on Dyslipidaemia. | Eur Cardiol | 2021 |